Index of reports
> Death (558)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 558 Next >>
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-27
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cisplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dexamethasone Sodium Phosphate
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Gemcitabine Hydrochloride
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Ifosfamide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Rituximab
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Vinblastine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Possible Carboplatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-08-17
Pemetrexed Disodium
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Possible Carboplatin side effects in 58 year old male
Reported by a consumer/non-health professional from Argentina on 2012-08-24
Patient: 58 year old male
Reactions: Hepatotoxicity, Neoplasm Malignant, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-01-01
Yervoy
Dosage: no of inf:2 infusion on 9feb12
Indication: Metastatic Malignant Melanoma
Start date: 2012-02-09
Possible Carboplatin side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Dexamethasone
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Carboplatin side effects in male
Reported by a physician from Hungary on 2012-08-22
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Pneumonia, Anaemia, Granulocytopenia, Neutropenia, Thrombocytopenia, Leukopenia, Infectious Pleural Effusion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: frequency: 1x, form infusion;
Indication: non-Small Cell Lung Cancer
Avastin
Dosage: frequency as per protocol, last dose of prior to event on 25 january 2010. form infusion
Avastin
Dosage: last dose prior to sae: 16 february 2010. last dose prior to leukopenia was 23 mar 2010
Avastin
Dosage: last dose prior to sae: 16 february 2010,infusion, frequency: 1xdaily
Carboplatin
Dosage: last dose prior to event on 25 january 2010.
Carboplatin
Dosage: form: infusion;
Indication: non-Small Cell Lung Cancer
Carboplatin
Dosage: last dose prior to sae: 23 march 2010, frequency: 1xdaily
Carboplatin
Gemcitabine Hydrochloride
Dosage: last dose prior to sae: 01 april 2010
Gemcitabine Hydrochloride
Gemcitabine Hydrochloride
Dosage: freq: day 1 + 8 every 3 weeks
Gemcitabine Hydrochloride
Dosage: last dose of iv gemcitabine prior to event on 25 january 2010.
Gemcitabine Hydrochloride
Dosage: freq: day 1 + 8 every 3 weeks
Gemcitabine Hydrochloride
Dosage: form infusion, on day 1 and day 8; frequency: 1xdaily;
Indication: non-Small Cell Lung Cancer
Start date: 2009-11-09
End date: 2009-11-17
Gemcitabine Hydrochloride
Dosage: frequency: 2xevery three week, form: infusion
Other drugs received by patient: Fluticasone Propionate / Salmeterol; Augmentin '500'; Kalium-R; Sinecod; Ondansetron; Bisoprolol Fumarate; Pegfilgrastim; Lidocaine; Ciprofloxacin Hydrochloride; Neupogen; Spiriva; Kalium-R; Eprex; Neorecormon; Hydromorphone HCL; Berodual; Fluticasone Propionate / Salmeterol; Neorecormon; Augmentin '500'; Kalium-R; Medrol; Medrol; Neupogen; Medrol; Bisoprolol Fumarate; Spiriva; Megesin; Megesin
Possible Carboplatin side effects in 63 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-22
Patient: 63 year old male
Reactions: Circulatory Collapse
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: recent dose:20apr12
Indication: Head and Neck Cancer
Start date: 2012-03-05
End date: 2012-04-20
Cetuximab
Dosage: 400mg/m2:05mar12-unk, 250mg/m2:unk-16apr12. recent dose:16apr12
Indication: Head and Neck Cancer
Start date: 2012-03-05
Fluorouracil
Dosage: recent dose:16apr12
Indication: Head and Neck Cancer
Start date: 2012-03-05
End date: 2012-04-20
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-21
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-08-20
Patient: male
Reactions: Pneumonia Aspiration, Haemoptysis
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Avastin
Indication: Lung Adenocarcinoma
Carboplatin
Indication: Lung Adenocarcinoma
Pemetrexed
Indication: Lung Adenocarcinoma
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Germany on 2012-08-20
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: dose reduced
Start date: 2010-06-15
End date: 2010-07-22
Carboplatin
Dosage: form: vialsdose level: 5 auc
Start date: 2010-05-04
Docetaxel
Dosage: dose: 60mg/m2, form:vials
Start date: 2010-05-04
Docetaxel
Dosage: dose reduced, form:vials
Start date: 2010-06-15
End date: 2010-07-22
Trastuzumab
Dosage: dose level: 6mg/kgform: vials
Start date: 2010-05-04
End date: 2010-07-22
Other drugs received by patient: Metoclopramide; Bisoprolol Fumarate; Ondansetron; Dexamethasone; Emend; Loperamide
Possible Carboplatin side effects in 59 year old male
Reported by a physician from United States on 2012-08-20
Patient: 59 year old male, weighing 92.1 kg (202.6 pounds)
Reactions: Oesophageal Fistula, Post Procedural Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: on day 1 over 30-90 minutes, last dose prior to the event: 23/may/2012
Indication: Head and Neck Cancer
Start date: 2012-05-23
Carboplatin
Dosage: auc 6 over 30 minutes on day 1, last dose prior to the event: 12/jul/2012
Indication: Head and Neck Cancer
Start date: 2012-05-23
Docetaxel
Dosage: over 1 hour on day 1, last dose prior to the event: 12/jul/2012
Indication: Head and Neck Cancer
Start date: 2012-05-23
Possible Carboplatin side effects in 22 year old male
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient: 22 year old male, weighing 83.0 kg (182.6 pounds)
Reactions: Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Carboplatin
Etoposide
Sprycel
Other drugs received by patient: Medrol; Phenergan HCL; Ativan; Reglan
Possible Carboplatin side effects in 69 year old female
Reported by a physician from Belgium on 2012-08-17
Patient: 69 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-19
Carboplatin
Dosage: 720 mg, unk
Start date: 2006-11-30
Carboplatin
Dosage: 830 mg, unk
Start date: 2006-11-09
Etoposide
Dosage: 190 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Etoposide
Dosage: 1600 mg, unk
Start date: 2007-01-16
Filgrastim
Dosage: 6000 mug, qd (day 6 to day 13)
Indication: Diffuse Large B-Cell Lymphoma
Ifosfamide
Dosage: 9600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-19
Ifosfamide
Dosage: 9400 mg, unk
Start date: 2006-11-09
Ifosfamide
Dosage: 9500 mg, unk
Start date: 2006-11-30
Rituximab
Dosage: 720 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-08
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-29
Other drugs received by patient: Melphalan Hydrochloride; Cytarabine; Carmustine
Possible Carboplatin side effects in female
Reported by a individual with unspecified qualification from Belgium on 2012-08-15
Patient: female, weighing 94.9 kg (208.8 pounds)
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Diffuse Large B-Cell Lymphoma Stage IV
Start date: 2006-10-19
Carboplatin
Start date: 2006-11-09
Carboplatin
Start date: 2006-11-30
Etoposide
Start date: 2006-11-08
Etoposide
Indication: Diffuse Large B-Cell Lymphoma Stage IV
Start date: 2006-10-18
Etoposide
Start date: 2006-10-19
Etoposide
Start date: 2006-10-20
Etoposide
Start date: 2006-11-29
Etoposide
Start date: 2006-11-30
Etoposide
Start date: 2006-11-09
Etoposide
Start date: 2006-11-10
Etoposide
Start date: 2006-12-01
Ifosfamide
Indication: Diffuse Large B-Cell Lymphoma Stage IV
Start date: 2006-10-19
Ifosfamide
Start date: 2006-11-09
Ifosfamide
Start date: 2006-11-30
Pegfilgrastim
Dosage: 6000 ug/day
Indication: Diffuse Large B-Cell Lymphoma Stage IV
Rituximab
Start date: 2006-11-08
Rituximab
Indication: Diffuse Large B-Cell Lymphoma Stage IV
Start date: 2006-10-16
Rituximab
Start date: 2006-10-18
Rituximab
Start date: 2006-11-29
Other drugs received by patient: Cordarone; Combivent; Zantac; Zantac; Cordarone; Combivent
Possible Carboplatin side effects in 52 year old male
Reported by a physician from Germany on 2012-08-14
Patient: 52 year old male, weighing 105.2 kg (231.4 pounds)
Reactions: Gastric Ulcer Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose administered 1575 mg on 05/june/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Carboplatin
Dosage: last dose administered 432 mg on 05/june/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Megf0444a (Anti-Egfl7)
Dosage: last dose - 05/june/2012, 605 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Paclitaxel
Dosage: last dose administered 432 mg on 05/june/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Other drugs received by patient: Ondansetron; Dexamethasone; Erythrocyte Transfusions; Diclofenac; ACC Long; Ibuprofen; Clemastine Fumarate; Oxazepam; Fresh Frozen Plasma; Omeprazole; Ranitidine; Zopiclon
Possible Carboplatin side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Carboplatin side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Carboplatin side effects in 71 year old male
Reported by a physician from Japan on 2012-08-14
Patient: 71 year old male, weighing 45.0 kg (99.0 pounds)
Reactions: Haemoglobin Decreased, Diarrhoea, Febrile Neutropenia, Gastroenteritis Staphylococcal, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: 220 mg, single
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2011-12-21
End date: 2011-12-21
Carboplatin
Dosage: 210 mg, single
Start date: 2012-02-28
End date: 2012-02-28
Carboplatin
Dosage: 220 mg, single
Start date: 2012-01-20
End date: 2012-01-20
Irinotecan Hydrochloride
Dosage: 70 mg, single
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2011-12-21
End date: 2011-12-21
Irinotecan Hydrochloride
Dosage: 60 mg, single
Start date: 2012-03-06
End date: 2012-03-06
Irinotecan Hydrochloride
Dosage: 60 mg, single
Start date: 2012-02-28
End date: 2012-02-28
Irinotecan Hydrochloride
Dosage: 70 mg, single
Start date: 2011-12-28
End date: 2011-12-28
Irinotecan Hydrochloride
Dosage: 70 mg, single
Start date: 2012-01-20
End date: 2012-01-20
Irinotecan Hydrochloride
Dosage: 70 mg, single
Start date: 2012-01-27
End date: 2012-01-27
Other drugs received by patient: NEU-UP; Ambisome; Lansoprazole; Decadron Phosphate; Vancomycin Hydrochloride; Zyvox; Kremezin; Platelets, Human Blood; Allopurinol; Maxipime; Loperamide Hydrochloride; Itraconazole; Targocid; Meropenem; BIO Three; Gran; Medrol
Possible Carboplatin side effects in 58 year old female
Reported by a physician from United States on 2012-08-13
Patient: 58 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Obstruction Gastric, Vomiting, Hyperkalaemia, Nausea, Supraventricular Tachycardia, Febrile Neutropenia, Aspiration, Sepsis, Abdominal Distension, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose administered on 12/may/2011
Indication: Endometrial Cancer
Start date: 2012-05-12
Carboplatin
Dosage: auc=6; last dose administered on:12/may/2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Ixabepilone
Dosage: last dose administerd:12/may/2011
Indication: Endometrial Cancer
Start date: 2012-05-12
Other drugs received by patient: Protonix; Norco; Compazine; Synthroid; Ventolin; Lovenox
Possible Carboplatin side effects in female
Reported by a physician from Belgium on 2012-08-13
Patient: female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: cycle 1 day 2
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-19
Carboplatin
Dosage: cycle 2 day 2
Start date: 2006-11-09
Carboplatin
Dosage: cycle 3 day 2
Start date: 2006-11-30
Etoposide
Dosage: cycle 1 day 3
Etoposide
Start date: 2007-01-16
Etoposide
Dosage: cycle 1 day 1
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-16
Etoposide
Dosage: cycle 1 day 2
Filgrastim
Dosage: dose 6000 ug/day from d6 to d13 of cycle 1,2 and 3
Indication: Diffuse Large B-Cell Lymphoma
Ifosfamide
Dosage: cycle 3 day 2
Start date: 2006-11-30
Ifosfamide
Dosage: cycle 1 day 2
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-02-19
Ifosfamide
Dosage: cycle 2 day 2
Start date: 2006-11-09
Mabthera
Dosage: cycle 1 day 2
Mabthera
Dosage: cycle 3 day 1
Start date: 2006-11-29
Mabthera
Dosage: cycle 2 day 1
Start date: 2006-11-08
Mabthera
Dosage: cycle 1 day 1
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-16
Other drugs received by patient: Melphalan Hydrochloride; Cytarabine; Carmustine
Possible Carboplatin side effects in 69 year old female
Reported by a physician from Belgium on 2012-08-10
Patient: 69 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 830 mg, unk
Start date: 2006-11-09
Carboplatin
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-19
Carboplatin
Dosage: 720 mg, unk
Start date: 2006-11-30
Etoposide
Dosage: 190 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Etoposide
Dosage: 1600 mg, unk
Start date: 2007-01-16
Filgrastim
Dosage: 6000 mug, qd (day 6 to day 13)
Indication: Diffuse Large B-Cell Lymphoma
Ifosfamide
Dosage: 9600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-02-19
Ifosfamide
Dosage: 9400 mg, unk
Start date: 2006-11-09
Ifosfamide
Dosage: 9500 mg, unk
Start date: 2006-11-30
Rituximab
Dosage: 720 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-08
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-29
Other drugs received by patient: Carmustine; Cytarabine; Melphalan Hydrochloride
Possible Carboplatin side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-10
Patient: 65 year old male
Reactions: Multi-Organ Failure, Gastrointestinal Haemorrhage, Dermatitis, Interstitial Lung Disease, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Pharyngeal Cancer Stage Unspecified
Cetuximab
Dosage: loading dose:600mg then 400mg
Indication: Pharyngeal Cancer Stage Unspecified
Taxol
Indication: Pharyngeal Cancer Stage Unspecified
Possible Carboplatin side effects in female
Reported by a physician from France on 2012-08-10
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Musculoskeletal Chest Pain, Respiratory Distress, Bronchial Obstruction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Start date: 2011-01-31
End date: 2011-04-04
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2011-01-31
End date: 2011-04-04
Pemetrexed Disodium
Indication: non-Small Cell Lung Cancer
Start date: 2011-05-23
End date: 2011-08-04
Possible Carboplatin side effects in 69 year old female
Reported by a physician from Belgium on 2012-08-10
Patient: 69 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 830 mg, unk
Start date: 2006-11-09
Carboplatin
Dosage: 720 mg, unk
Start date: 2006-11-30
Carboplatin
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-19
Etoposide
Dosage: 190 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Etoposide
Dosage: 1600 mg, unk
Start date: 2007-01-16
Filgrastim
Dosage: 6000 mug, qd (day 6 to day 13)
Indication: Diffuse Large B-Cell Lymphoma
Ifosfamide
Dosage: 9600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-02-19
Ifosfamide
Dosage: 9400 mg, unk
Start date: 2006-11-09
Ifosfamide
Dosage: 9500 mg, unk
Start date: 2006-11-30
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-29
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-08
Rituximab
Dosage: 720 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Other drugs received by patient: Cytarabine; Carmustine; Melphalan Hydrochloride
Possible Carboplatin side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 58 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Obstruction Gastric, Vomiting, Hyperkalaemia, Nausea, Supraventricular Tachycardia, Febrile Neutropenia, Aspiration, Sepsis, Abdominal Distension, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: last administered 12may2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Carboplatin
Dosage: last administered 12may2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Ixabepilone
Dosage: last administered 12may2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Other drugs received by patient: Norco; Compazine; Synthroid; Ventolin; Protonix; Lovenox
Possible Carboplatin side effects in 52 year old male
Reported by a physician from Germany on 2012-08-09
Patient: 52 year old male, weighing 105.2 kg (231.4 pounds)
Reactions: Gastric Ulcer Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose administered 1575 mg on 05/june/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Carboplatin
Dosage: last dose administered 432 mg on 05/june/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Megf0444a (Anti-Egfl7)
Dosage: last dose - 05/june/2012, 605 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Paclitaxel
Dosage: last dose administered 432 mg on 05/june/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-24
Other drugs received by patient: Diclofenac; Omeprazole; Ibuprofen
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-07
Patient: female, weighing 69.9 kg (153.8 pounds)
Reactions: Urinary Tract Infection, Bacterial Sepsis, Abscess, Peritonitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 792 mg
End date: 2011-08-10
Herceptin
Dosage: 140 mg
End date: 2011-08-10
Taxotere
Dosage: 130 mg
End date: 2011-08-10
Possible Carboplatin side effects in female
Reported by a physician from China on 2012-08-06
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Death, Cardiac Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: most recent dose prior to the event: 21/mar/2012, 840 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Carboplatin
Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Paclitaxel
Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Possible Carboplatin side effects in 69 year old female
Reported by a physician from Belgium on 2012-08-06
Patient: 69 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-19
Carboplatin
Dosage: 720 mg, unk
Start date: 2006-11-30
Carboplatin
Dosage: 830 mg, unk
Start date: 2006-11-09
Etoposide
Dosage: 190 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Etoposide
Dosage: 1600 mg, unk
Start date: 2007-01-16
Ifosfamide
Dosage: 9500 mg, unk
Start date: 2006-11-30
Ifosfamide
Dosage: 9600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-02-19
Ifosfamide
Dosage: 9400 mg, unk
Start date: 2006-11-09
Pegfilgrastim
Dosage: 6000 mug, qd (day 6 to day 13)
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 720 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-10-18
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-29
Rituximab
Dosage: 710 mg, unk
Start date: 2006-11-08
Other drugs received by patient: Cytarabine; Melphalan Hydrochloride; Carmustine
Page 1 Next >>
|